(ALKS) Alkermes - Performance 18.8% in 12m
ALKS performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
47.12%
#9 in Peer-Group
Rel. Strength
65.06%
#2596 in Stock-Universe
Total Return 12m
18.84%
#49 in Peer-Group
Total Return 5y
47.66%
#20 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | 13.8 |
| P/E Forward | 20.0 |
| High / Low | USD |
|---|---|
| 52 Week High | 36.00 USD |
| 52 Week Low | 23.01 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 23.60 |
| Buy/Sell Signal +-5 | -0.04 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: ALKS (18.8%) vs XBI (-10.7%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
3.32% | 68% | 77.8% | 22.7 | 13.6 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-10.6% | -8.81% | 144% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
0.71% | -3.57% | 32.5% | 25.4 | 13.4 | 0.93 | 0.60% | 41% |
| BIM PA Biomerieux |
-0.36% | 31.7% | -6.18% | 33.1 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
2.76% | -8.64% | 0.27% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
12.5% | 65.3% | -5.65% | 25.5 | 22.8 | 0.91 | 48.1% | 3.93% |
| PTCT NASDAQ PTC Therapeutics |
-0.49% | 55.9% | -10.1% | 7.71 | 6.26 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
3.44% | 35.3% | 14.7% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: ALKS vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for ALKS
| Total Return (including Dividends) | ALKS | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -7.37% | 2.27% | 4.52% |
| 3 Months | -10.90% | 6.30% | 10.43% |
| 12 Months | 18.84% | -10.68% | 14.67% |
| 5 Years | 47.66% | -26.13% | 109.23% |
| Trend Score (consistency of price movement) | ALKS | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -94.4% | 5.5% | 79.1% |
| 3 Months | 16.2% | 74.3% | 94.2% |
| 12 Months | 65.9% | -84.7% | 44.4% |
| 5 Years | 61.5% | -52.6% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th31.50 | -9.43% | -11.37% |
| 3 Month | %th28.50 | -16.18% | -19.31% |
| 12 Month | %th76.00 | 33.04% | 3.63% |
| 5 Years | %th90.50 | 99.89% | -29.43% |
FAQs
Does Alkermes (ALKS) outperform the market?
Yes,
over the last 12 months ALKS made 18.84%, while its related Sector, the SPDR S&P Biotech (XBI) made -10.68%.
Over the last 3 months ALKS made -10.90%, while XBI made 6.30%.
Performance Comparison ALKS vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
ALKS vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -3% | -11.9% | -5.5% | 4% |
| US NASDAQ 100 | QQQ | -2.6% | -12% | -6.7% | 5% |
| German DAX 40 | DAX | -1.3% | -6.3% | -16.9% | -10% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -2.1% | -11.5% | -6.4% | 1% |
| Hongkong Hang Seng | HSI | -1.3% | -13.4% | -23.2% | -17% |
| India NIFTY 50 | INDA | -3.1% | -9.8% | -3.8% | 19% |
| Brasil Bovespa | EWZ | -4.1% | -14.9% | -28.3% | 6% |
ALKS vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -3.6% | -13.4% | -10.6% | -9% |
| Consumer Discretionary | XLY | -2.5% | -9.4% | 1.8% | -1% |
| Consumer Staples | XLP | -2% | -7% | -5.1% | 8% |
| Energy | XLE | -1.9% | -11.7% | 0.6% | 22% |
| Financial | XLF | -3.3% | -11% | -9.2% | -11% |
| Health Care | XLV | -3.4% | -10.9% | 0.6% | 23% |
| Industrial | XLI | -3.3% | -11.5% | -12.6% | -6% |
| Materials | XLB | -4% | -11.6% | -8.5% | 13% |
| Real Estate | XLRE | 0.1% | -8.1% | -4.3% | 6% |
| Technology | XLK | -2.8% | -15.3% | -7.7% | 8% |
| Utilities | XLU | -1.7% | -7.8% | -8.1% | -6% |
| Aerospace & Defense | XAR | -3.7% | -14.6% | -23.9% | -30% |
| Biotech | XBI | -0.4% | -9.6% | 10% | 30% |
| Homebuilder | XHB | -5.6% | -17.9% | 1.1% | 14% |
| Retail | XRT | -4% | -11.8% | 0.3% | 9% |
ALKS vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | -2.5% | -13.7% | 4.72% | 28% |
| Natural Gas | UNG | 5.8% | 3.1% | 12% | 28% |
| Gold | GLD | -1.7% | -6.1% | -24.5% | -24% |
| Silver | SLV | -1.6% | -11% | -20.7% | -3% |
| Copper | CPER | -4.1% | -11.3% | -23.9% | 4% |
ALKS vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | -2.1% | -10.9% | -1.6% | 17% |
| iShares High Yield Corp. Bond | HYG | -1.2% | -8.6% | -3.3% | 9% |